We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Clinical guide · Menopause
How to use HRT safely when endometriosis is part of your history — including the protocol that changes after hysterectomy.
Reviewed by the kindr Health medical team · Last reviewed July 22, 2026
In short: Endometriosis does not rule out hormone replacement therapy (HRT). But estrogen-only therapy is not the right choice — even if your uterus has been removed. Guideline-aligned care uses a combined estrogen + progestogen regimen (or tibolone) to keep any residual endometriotic tissue quiet, treat vasomotor and genitourinary symptoms, and protect long-term bone and cardiovascular health.
Endometriosis is an estrogen-driven disease. Even after natural menopause or surgical removal of the uterus and ovaries, microscopic endometrial-like implants can remain in the pelvis, bowel wall, bladder, or (rarely) further afield. When exogenous estrogen is given without a progestogen, those implants can be reactivated. Documented consequences include:
This is why the guideline stance across NAMS/The Menopause Society, ESHRE, ACOG, and the Endocrine Society is consistent: in women with a personal history of endometriosis, use combined therapy or tibolone rather than estrogen alone — and do so under clinical supervision.
Standard combined HRT applies: transdermal or oral estradiol paired with a progestogen (micronized progesterone, or a levonorgestrel IUS for endometrial protection). The progestogen is required both to protect the uterine lining and to suppress any extra-uterine implants. Continuous combined regimens are usually preferred over cyclic ones in postmenopause.
This is the scenario most often mishandled. Because the uterus is gone, clinicians historically prescribed estrogen alone. In endometriosis this is not appropriate:
Low-dose vaginal estrogen (cream, tablet, ring) or intravaginal DHEA treats genitourinary syndrome of menopause with minimal systemic absorption. It is generally considered safe in women with a history of endometriosis and does not require adding a systemic progestogen on its own.
Kindr Health pairs you with a menopause-trained clinician who will review your endometriosis history and build a protocol that treats symptoms without reactivating disease.
Start your menopause consult →Yes, in most cases — but the protocol matters. Because residual endometrial-like tissue can be re-stimulated by estrogen, guideline-aligned care uses combined estrogen + progestogen (or tibolone) rather than estrogen alone, even after hysterectomy. A menopause-trained clinician should individualize the plan.
Endometriotic implants outside the uterus can persist after menopause or hysterectomy. Unopposed estrogen can reactivate these implants and, in rare cases, has been linked to malignant transformation. Adding a progestogen suppresses that stimulation.
NAMS/The Menopause Society and ESHRE both recommend adding a progestogen (or using tibolone) for at least several years after surgical menopause when endometriosis was the reason for hysterectomy — even without a uterus — because implants elsewhere can remain estrogen-responsive.
For many women pain improves as estrogen falls. A minority have persistent or recurrent pain after menopause, especially with deep infiltrating disease or after starting HRT. Report new pelvic pain, bleeding, or bloating promptly.
Women who lose ovarian function before the natural menopause age carry higher long-term risks (bone, heart, brain). Guidelines generally support HRT at least until the average age of menopause (~51), using combined therapy or tibolone when endometriosis is part of the history.
Low-dose local vaginal estrogen for genitourinary symptoms is generally considered safe because systemic absorption is minimal. Discuss any active disease or unusual symptoms with your clinician before starting.
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reviewed by the Kindr Health medical team · Last reviewed 2026-07-22.